Business Description
Petros Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US71678J2096
Share Class Description:
PTPI: Ordinary SharesDescription
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.61 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 0.66 | |||||
| Debt-to-EBITDA | -1.97 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -4.2 | |||||
| Beneish M-Score | -3.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -46.9 | |||||
| 3-Year EBITDA Growth Rate | 56.2 | |||||
| 3-Year EPS without NRI Growth Rate | 29.1 | |||||
| 3-Year FCF Growth Rate | 50.4 | |||||
| 3-Year Book Growth Rate | -39.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.79 | |||||
| 9-Day RSI | 20.09 | |||||
| 14-Day RSI | 23.83 | |||||
| 6-1 Month Momentum % | -1.27 | |||||
| 12-1 Month Momentum % | -65.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.89 | |||||
| Quick Ratio | 1.74 | |||||
| Cash Ratio | 1.24 | |||||
| Days Inventory | 453.75 | |||||
| Days Sales Outstanding | 154.05 | |||||
| Days Payable | 380.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -45.5 | |||||
| Shareholder Yield % | 31.43 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.97 | |||||
| Operating Margin % | -184.84 | |||||
| Net Margin % | -140.2 | |||||
| FCF Margin % | -130.96 | |||||
| ROE % | -63.16 | |||||
| ROA % | -24.83 | |||||
| ROIC % | -58.7 | |||||
| ROC (Joel Greenblatt) % | -2329.57 | |||||
| ROCE % | -30.84 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.23 | |||||
| PB Ratio | 0.16 | |||||
| Price-to-Tangible-Book | 0.62 | |||||
| EV-to-EBIT | 0.03 | |||||
| EV-to-EBITDA | 0.06 | |||||
| EV-to-Revenue | -0.04 | |||||
| EV-to-FCF | 0.03 | |||||
| Earnings Yield (Greenblatt) % | 3333.33 | |||||
| FCF Yield % | -173.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PTPI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Petros Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.823 | ||
| EPS (TTM) ($) | -6.34 | ||
| Beta | 2.18 | ||
| Volatility % | 250.89 | ||
| 14-Day RSI | 23.83 | ||
| 14-Day ATR ($) | 0.095866 | ||
| 20-Day SMA ($) | 0.827075 | ||
| 12-1 Month Momentum % | -65.78 | ||
| 52-Week Range ($) | 0.602 - 5.2399 | ||
| Shares Outstanding (Mil) | 6.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Petros Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Petros Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Petros Pharmaceuticals Inc Frequently Asked Questions
What is Petros Pharmaceuticals Inc(PTPI)'s stock price today?
The current price of PTPI is $0.64. The 52 week high of PTPI is $5.24 and 52 week low is $0.60.
When is next earnings date of Petros Pharmaceuticals Inc(PTPI)?
The next earnings date of Petros Pharmaceuticals Inc(PTPI) is .
Does Petros Pharmaceuticals Inc(PTPI) pay dividends? If so, how much?
Petros Pharmaceuticals Inc(PTPI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers